![Michael Kaseta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Kaseta
Directeur Financier/CFO chez
LIQUIDIA CORPORATION
Fortune : 24 M $ au 31/08/2026
Profil
Michael Kaseta currently works at Bryn Pharma LLC, as Director from 2023, Heron Therapeutics, Inc., as Independent Director from 2024, Liquidia Corp., as Chief Financial & Operating Officer from 2024, and Liquidia Technologies, Inc., as Chief Financial & Operating Officer from 2020.
Mr. Kaseta also formerly worked at Alimera Sciences, Inc., as Independent Director from 2023 to 2024, Sanofi, as Chief Financial Officer-Sanofi North America from 2015 to 2016, Aerami Therapeutics, Inc., as Chief Financial Officer from 2019 to 2020, and Old API Wind-down Ltd., as Chief Financial & Accounting Officer from 2018 to 2019.
Mr. Kaseta received his undergraduate degree from James Madison University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0,39 % | 13/07/2026 | 345 805 ( 0,39 % ) | 24 M $ | 31/08/2026 |
HERON THERAPEUTICS INC 0,02 % | 14/04/2026 | 29 787 ( 0,02 % ) | 9 472 $ | 31/08/2026 |
Postes actifs de Michael Kaseta
| Sociétés | Poste | Début |
|---|---|---|
| LIQUIDIA CORPORATION | Directeur Financier/CFO | 30/11/2020 |
| HERON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 04/11/2024 |
Bryn Pharma LLC
 Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Directeur/Membre du Conseil | 02/05/2023 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Directeur Financier/CFO | 20/08/2020 |
Anciens postes connus de Michael Kaseta
| Sociétés | Poste | Fin |
|---|---|---|
| ALIMERA SCIENCES, INC. | Directeur/Membre du Conseil | 16/09/2024 |
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Directeur Financier/CFO | 01/11/2020 |
| OLD API WIND-DOWN LTD. | Directeur Financier/CFO | 01/01/2019 |
| SANOFI | Corporate Officer/Principal | 01/09/2016 |
Formation de Michael Kaseta
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Alimera Sciences, Inc.
 Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
James Madison University
 James Madison University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Health Technology |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Health Technology |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
